|
| 37536727 | Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist. | | 2023 |
| 37009688 | : a novel immune modulator in breast cancer? | | 2023 |
| 35169671 | The EXIMIOUS project-Mapping exposure-induced immune effects: connecting the exposome and the immunome. | Environmental Epidemiology | 2022 |
| 35713672 | Characterization of Bacteria Using Surface-Enhanced Raman Spectroscopy (SERS): Influence of Microbiological Factors on the SERS Spectra. | Analytical Chemistry | 2022 |
| 35565537 | The Effects of Ledeb, Bunge, and Roxb on Broiler Performance, Nutrient Digestibility, and Gastrointestinal Tract Microorganisms. | Animals | 2022 |
| 36006824 | Whole-genome analysis of strains isolated from persons with cystic fibrosis. | | 2022 |
| 35486871 | Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease Persistence. | American Journal of Respiratory Cell and Molecular Biology | 2022 |
| 35549675 | Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections. | BMC Microbiology | 2022 |
| 35730434 | Taxonomic position, antibiotic resistance and virulence factors of clinical isolates. | Frontiers in Bioscience - Scholar | 2022 |
| 35610571 | Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection. | BMC Microbiology | 2022 |
| 35265731 | Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy. | Open Forum Infectious Diseases | 2022 |
| 34463860 | Characterization of clinical Ralstonia strains and their taxonomic position. | Antonie van Leeuwenhoek | 2021 |
| 35368453 | Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs. | Frontiers in Cellular and Infection Microbiology | 2021 |
| 33750479 | Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes. | Antimicrobial Resistance and Infection Control | 2021 |
| 34283223 | Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates. | Journal of Antimicrobial Chemotherapy | 2021 |
| 33549519 | Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor. | Journal of Cystic Fibrosis | 2021 |
| 33367642 | Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates. | Journal of Antimicrobial Chemotherapy | 2021 |
| 32855225 | Efficacy and safety of TOBI Podhaler in infected bronchiectasis patients: iBEST study. | European Respiratory Journal | 2021 |
| 31364220 | Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis. | Respirology | 2020 |
| 32238195 | Lung function and microbiota diversity in cystic fibrosis. | Microbiome | 2020 |
| 32059649 | Developing evidence-based guidance for assessment of suspected infections in care home residents. | BMC Geriatrics | 2020 |
| 31767727 | Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics. | Antimicrobial Agents and Chemotherapy | 2020 |
| 32217675 | Draft Genome Sequence of a Haemophilus parainfluenzae Strain Isolated from a Patient with Chronic Obstructive Pulmonary Disease. | Microbiology Resource Announcements | 2020 |
| 31927037 | Antimicrobial stewardship in care homes: outcomes of importance to stakeholders. | Journal of Hospital Infection | 2020 |
| 31812487 | Influence of azithromycin and allograft rejection on the post-lung transplant microbiota. | Journal of Heart and Lung Transplantation | 2020 |
| 33083441 | Multiple breath washout in bronchiectasis clinical trials: is it feasible? | ERJ Open Research | 2020 |
| 33013411 | Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis? | Frontiers in Pharmacology | 2020 |
| 32604894 | Antibacterial Activity of Four Plant Extracts Extracted from Traditional Chinese Medicinal Plants against and subsp. serovar Enteritidis. | Microorganisms | 2020 |
| 30709744 | Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review. | Journal of Cystic Fibrosis | 2019 |
| 31847850 | Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens. | Respiratory Research | 2019 |
| 31762328 | Whole-genome analysis of species strains from cystic fibrosis patients. | Future Microbiology | 2019 |
| 31753887 | Multifaceted intervention to Reduce Antimicrobial Prescribing in Care Homes: a process evaluation of a UK-based non-randomised feasibility study. | BMJ Open | 2019 |
| 30545985 | British Thoracic Society Guideline for bronchiectasis in adults. | Thorax | 2019 |
| 30487080 | The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis? | Journal of Cystic Fibrosis | 2019 |
| 30240837 | Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients. | International Journal of Antimicrobial Agents | 2019 |
| 31171614 | Draft Genome Sequence of Haemophilus haemolyticus Strain 16/010 O, Isolated from a Sputum Sample from a Cystic Fibrosis Patient. | Microbiology Resource Announcements | 2019 |
| 31433997 | Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1). | Pulmonary Pharmacology and Therapeutics | 2019 |
| 30905581 | Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis. | Journal of Cystic Fibrosis | 2019 |
| 30675682 | Interventions to Improve Antimicrobial Stewardship for Older People in Care Homes: A Systematic Review. | Drugs and Aging | 2019 |
| 31350337 | A general protein glycosylation machinery conserved in species improves bacterial fitness and elicits glycan immunogenicity in humans. | Journal of Biological Chemistry | 2019 |
| 31304176 | Community analysis and co-occurrence patterns in airway microbial communities during health and disease. | ERJ Open Research | 2019 |
| 30687502 | British Thoracic Society guideline for bronchiectasis in adults. | BMJ Open Respir Res | 2018 |
| 28822601 | Training in multiple breath washout testing for respiratory physiotherapists. | Physiotherapy | 2018 |
| 29037527 | CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor. | Chest | 2018 |
| 30219825 | Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum. | Journal of Antimicrobial Chemotherapy | 2018 |
| 30351435 | Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. | Journal of Antimicrobial Chemotherapy | 2018 |
| 29879161 | Criteria required for an acceptable point-of-care test for UTI detection: Obtaining consensus using the Delphi technique. | PLoS ONE | 2018 |
| 29875191 | Pathogen Eradication and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis. | Journal of Clinical Microbiology | 2018 |
| 29946004 | Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study. | European Respiratory Journal | 2018 |
| 29386349 | Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis. | European Respiratory Journal | 2018 |